Search
Avadel Pharmaceuticals PLC
AVDLAdd to Watchlist
21.326USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
2.12BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-02-11The current earnings forecast score of Avadel Pharmaceuticals PLC is 6.20, ranking 133 out of 159 in the Pharmaceuticals industry. The average price target is 22.00, with a high of 23.00 and a low of 18.50.
Analyst Rating
Based on
8
analysts
Hold
Current Rating
21.056
Target Price
-2.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Avadel Pharmaceuticals PLC
AVDL
8
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Avadel Pharmaceuticals PLC's expected revenue for the next quarter?
Avadel Pharmaceuticals PLC's expected revenue is 78.53M.
What is Avadel Pharmaceuticals PLC's price target?
Analysts forecast that Avadel Pharmaceuticals PLC's price target is USD 22.00, with the highest forecast at USD 23.00 and the lowest forecast at USD 18.50.
What is the analyst rating for Avadel Pharmaceuticals PLC?
Based on the ratings of Avadel Pharmaceuticals PLC's stock from 8 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
